EP2729498 - THERAPEUTIC COMBINATIONS OF ANTI -CD20 AND ANTI - GM - CSF ANTIBODIES AND USES THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.01.2017 Database last updated on 07.12.2019 | Most recent event Tooltip | 20.01.2017 | Application deemed to be withdrawn | published on 22.02.2017 [2017/08] | Applicant(s) | For all designated states MorphoSys AG Lena-Christ-Strasse 48 82152 Planegg-Martinsried / DE | [2014/20] | Inventor(s) | 01 /
STEIDL, Stefan Ebenböckstr. 25 81241 München / DE | [2014/20] | Representative(s) | Chiappinelli, Susan Ann
, et al
GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
Former [2014/20] | Sayce, Alastair George GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 12735498.3 | 06.07.2012 | WO2012EP63207 | Priority number, date | EP20110172865 | 06.07.2011 Original published format: EP 11172865 | US201161504744P | 06.07.2011 Original published format: US 201161504744 P | [2014/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013004806 | Date: | 10.01.2013 | Language: | EN | [2013/02] | Type: | A1 Application with search report | No.: | EP2729498 | Date: | 14.05.2014 | Language: | EN | The application has been published by WIPO in one of the EPO official languages on 10.01.2013 | [2014/20] | Search report(s) | International search report - published on: | EP | 10.01.2013 | Classification | International: | C07K16/28, C07K16/24, A61K39/395 | [2014/20] | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/20] | Extension states | BA | 22.01.2014 | ME | 22.01.2014 | Title | German: | THERAPEUTISCHE KOMBINATIONEN VON ANTI-CD20- UND ANTI-GM-CSF-ANTIKÖRPERN UND VERWENDUNGEN DAVON | [2014/20] | English: | THERAPEUTIC COMBINATIONS OF ANTI -CD20 AND ANTI - GM - CSF ANTIBODIES AND USES THEREOF | [2014/20] | French: | ASSOCIATIONS THÉRAPEUTIQUES D'ANTICORPS ANTI-CD20 ET ANTI-GM-CSF, ET LEURS UTILISATIONS | [2014/20] | Entry into regional phase | 22.01.2014 | National basic fee paid | 22.01.2014 | Designation fee(s) paid | 22.01.2014 | Examination fee paid | Examination procedure | 22.01.2014 | Examination requested [2014/20] | 19.08.2014 | Amendment by applicant (claims and/or description) | 11.03.2016 | Despatch of a communication from the examining division (Time limit: M06) | 22.09.2016 | Application deemed to be withdrawn, date of legal effect [2017/08] | 19.10.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/08] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 11.03.2016 | Fees paid | Renewal fee | 08.07.2014 | Renewal fee patent year 03 | 09.07.2015 | Renewal fee patent year 04 | 11.07.2016 | Renewal fee patent year 05 | Cited in | International search | [ID]WO2010124163 (THERACLONE SCIENCES INC [US], et al) [ID] 1-15 * paragraphs [0126] - [0128] - [ 0422] *; | [ID]WO2007092939 (MORPHOTEK INC [US], et al) [ID] 1-15 * page 22 - paragraphs 0042-0043, 0068 *; | [A]WO9411026 (IDEC PHARMA CORP [US]) [A] 1-15 * the whole document *; | [AD]WO2007064911 (BIOGEN IDEC INC [US], et al) [AD] 1-15 * the whole document * | [XDI] - SAKAGAMI TAKURO ET AL, "Patient-derived Granulocyte/Macrophage Colony-Stimulating Factor Autoantibodies Reproduce Pulmonary Alveolar Proteinosis in Nonhuman Primates", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, (201007), vol. 182, no. 1, pages 49 - 61, XP002663317 [XD] 1,4,6,8-12 * the whole document * [I] 1-15 DOI: http://dx.doi.org/10.1164/rccm.201001-0008oc | by applicant | WO2010115554 | WO0027428 | WO0047228 | WO03068821 | WO2006111353 | US2009297532 | WO2007049472 | US2008317757 | WO2009064399 | US2010122819 | WO03068920 | US2004053365 | WO2007092939 | US2008292641 | WO2008141391 | US2010297135 | WO2009038760 | WO2009062238 | WO2009134805 | US2009274706 | WO2010124163 | US2010291075 | WO2009133103 | US5736137 | US5595721 | WO03002607 | US5677180 | WO2004035607 | US2007136826 | - SAKAGAMI ET AL., AM J RESPIR CRIT CARE MED, (2010), vol. 182, pages 49 - 61 | - KAVURU ET AL., EUR RESPIR J., (2011), vol. 38, pages 1361 - 7 | - VALLERSKOG ET AL., CLIN IMMUNOL, (2007), vol. 122, pages 62 - 74 | - TING-CHAO CHOU, THEORETICAL BASIS, EXPERIMENTAL DESIGN, AND COMPUTERIZED SIMULATION OF SYNERGISM AND ANTAGONISM IN DRUG COMBINATION STUDIES, PHARMACOL REV, (2006), vol. 58, pages 621 - 681 | - BREAST CANCER RESEARCH AND TREATMENT, (1997), vol. 46, pages 255 - 278 | - CHOTHIA C; LESK AM., "Canonical structures for the hypervariable regions of immunoglobulins", J MOL BIOL., (1987), vol. 196, no. 4, doi:doi:10.1016/0022-2836(87)90412-8, pages 901 - 17, XP024010426 DOI: http://dx.doi.org/10.1016/0022-2836(87)90412-8 | - PRESS ET AL., BLOOD, (1987), vol. 69, no. 2, pages 584 - 591 | - VALENTINE ET AL., In: Leukocyte Typing III, OXFORD UNIVERSITY PRESS, (1987), page 440 | - INT J ONCOL., (201102), vol. 38, no. 2, pages 335 - 44 | - MOL IMMUNOL., (200805), vol. 45, no. 10, pages 2861 - 8 | - STANLEY ET AL., PROC. NATL. ACAD. SCI. USA, (1994), vol. 91, page 5592 | - MINARD-COLIN ET AL., BLOOD, (2008), vol. 112, pages 1205 - 13 | US20080675013 | US20030366709 |